Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accessed, accessing, add, alert, alfa, ambiguity, Amgen, Annex, Army, artilleryman, augment, augmentation, Baghdad, banned, BI, California, cardio, causal, CDMO, Chiron, chloride, Concurrently, contralateral, CRD, crime, Cubist, custodial, cyber, cycle, David, defective, deployment, destruction, detect, disaster, distressed, electrolyte, email, enhance, enlisted, epilepsy, EPO, Epygenix, FDIC, fellowship, firmly, FivePrime, flushing, freedom, fundamental, hardening, illiquidity, improper, incomplete, Indivior, insolvent, interplay, intractable, Invivo, IP, ipsilateral, Iraq, Iraqi, Israel, KR, lending, Ligand, Lorianne, lumen, malfeasance, Masuoka, Merck, military, misplaced, Nektar, Opiant, oversee, overseeing, PCT, penumbral, Pfenex, phenomenon, plastic, police, polyvinyl, predominately, prompt, Psychiatry, Purple, receivership, Republic, rescuing, rinvecalinase, safeguarding, sequelae, Silicon, software, steady, sterile, stolen, substance, surrender, syndrome, theft, training, transmission, unintentional, unstable, Valley, vulnerable, Wambeke, workload, Yale, yearly
Removed:
AB, abnormal, accelerated, accommodate, accumulation, agonist, aka, anniversary, antagonist, antibacterial, appealing, bacterial, basement, Bayer, bloodstream, bringing, canagliflozin, capillary, Captopril, cardiovascular, ChemoCentryx, Chinook, chosen, closed, collapse, collecting, College, combine, complication, contingent, converting, correlated, cure, Cyclin, dampen, declined, declining, dehydration, denying, diabetic, disabled, dismissal, dual, elimination, endothelin, ESRD, excreted, Farxiga, fat, filtering, flexibility, floor, formation, forward, Foundation, genital, Glycadia, glycation, glycemic, golden, greatest, hourly, improved, intact, intrinsic, inversely, invoiced, INVOKANA, judge, Jumpstart, Latin, leak, limb, linked, macroalbuminuria, mandatory, marker, membrane, microalbuminuria, Mineralcorticortisteroid, Mitsubishi, move, mycotic, NDA, nucleotide, objected, observational, opposition, parachute, PD, permanently, Pfizer, pharmacodynamic, phosphodiesterase, PK, predisposition, prematurely, prescribed, problem, pronounced, Reata, receptor, released, revised, rotation, show, sponsored, Squibb, suboptimal, sugar, Tanabe, thickening, transplant, Travere, unblinded, untreated, venue
Filing tables
Filing exhibits
Related press release
DMAC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 333-254089, 333-260066 and 333-273068) and Form S-8 (File Nos. 333-228821, 333-231717, 333-263543 and 333-266789) of DiaMedica Therapeutics Inc. of our report dated March 19, 2024, relating to the consolidated financial statements of DiaMedica Therapeutics Inc., which appears in this annual report on Form 10-K for the fiscal year ended December 31, 2023.
/s/ Baker Tilly US, LLP
Minneapolis, Minnesota
March 19, 2024